21 - Cardiovascular implantable electronic device (CIED) infections

Thursday, September 30, 2021

12:30 PM - 1:45 PM EDT

Moderator(s)

Jose M Miro, MD PhD

Dr.
Infectious Diseases Service
Hospital Clinic of Barelona
Barcelona, Catalonia, Spain

Abbvie (Individual(s) Involved: Self): Consultant; Angelini (Individual(s) Involved: Self): Consultant; Contrafect (Individual(s) Involved: Self): Consultant; Cubist (Individual(s) Involved: Self): Consultant; GENENTECH (Individual(s) Involved: Self): Consultant; Gilead (Individual(s) Involved: Self): Consultant
Larry Baddour, MD

Physician
Infectious Diseases
Mayo Clinic College of Medicine
Rochester, MN, United States

Boston Scientific (Individual(s) Involved: Self): Consultant; Botanix Pharmaceuticals (Individual(s) Involved: Self): Consultant; Roivant Sciences (Individual(s) Involved: Self): Consultant

Speaker(s)

Maria Elena Ruiz, MD

Director of Transplant Infectious Diseases, Assistant Section Chief of Infectious Diseases, Department of Medicine
MedStar Washington Hospital Center, Washington, DC, USA
Washington, DC, DC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Robin Patel, MD

Professor
Mayo Clinic
Rochester, MN, United States

BioFire (Individual(s) Involved: Self): Grant/Research Support; Contrafect (Individual(s) Involved: Self): Grant/Research Support; IDSA (Individual(s) Involved: Self): Editor's stipend; NBME, Up-to-Date and the Infectious Diseases Board Review Course (Individual(s) Involved: Self): Honoraria; Netflix (Individual(s) Involved: Self): Consultant; TenNor Therapeutics Limited (Individual(s) Involved: Self): Grant/Research Support; to Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST, Torus Biosystems, Mammoth Biosciences and Qvella (Individual(s) Involved: Self): Consultant
Jean-Claude Deharo, MD

Head Arrhythmia Department
Aix Marseille University
Marseille, France

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Jose M Miro, MD PhD: Abbvie (Individual(s) Involved: Self): Consultant; Angelini (Individual(s) Involved: Self): Consultant; Contrafect (Individual(s) Involved: Self): Consultant; Cubist (Individual(s) Involved: Self): Consultant; GENENTECH (Individual(s) Involved: Self): Consultant; Gilead (Individual(s) Involved: Self): Consultant

Larry M. Baddour, MD: Boston Scientific (Individual(s) Involved: Self): Consultant; Botanix Pharmaceuticals (Individual(s) Involved: Self): Consultant; Roivant Sciences (Individual(s) Involved: Self): Consultant

Maria Elena Ruiz, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Robin Patel, MD: BioFire (Individual(s) Involved: Self): Grant/Research Support; Contrafect (Individual(s) Involved: Self): Grant/Research Support; IDSA (Individual(s) Involved: Self): Editor's stipend; NBME, Up-to-Date and the Infectious Diseases Board Review Course (Individual(s) Involved: Self): Honoraria; Netflix (Individual(s) Involved: Self): Consultant; TenNor Therapeutics Limited (Individual(s) Involved: Self): Grant/Research Support; to Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST, Torus Biosystems, Mammoth Biosciences and Qvella (Individual(s) Involved: Self): Consultant

Jean-Claude Deharo, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:

Recognize the clinical picture and prognosis of cardiovascular implantable electronic device (CIED) infections
Identify the role and diagnostic yield of culture and molecular biology of CIED infections
Explain the surgical approach and the timing of CIED reimplantation and the potential role of Micra devices in the management of these infections

Presentations:

Clinical picture and prognosis
Speaker: Maria Elena Ruiz, MD – MedStar Washington Hospital Center, Washington, DC, USA
Microbiological Diagnosis: Role of Advanced Diagnostics
Speaker: Robin Patel, MD – Mayo Clinic
Removal & timing of reimplantation. Role new MICRA devices in CIED infections
Speaker: Jean-Claude Deharo, MD – Aix Marseille University